FDA Welcomes Variety of Phase 2/3 Trial Designs for COVID-19 Therapies | Bridget Silverman | 05/28/20 | National |
Bio Roundup: Sarepta’s Approval, Merck M&A, Drug Price Bill & More | Frank Vinluan | 12/13/19 | National |
Bio Roundup: Feds Sue Gilead, Biogen Eyes China, CRISPR’d Kidneys & More | Frank Vinluan | 11/08/19 | National |
Bio Roundup: PARP Progress, A New Commish, IPO-Palooza & More | Ben Fidler | 10/04/19 | National |